Biologic role of activated leukocyte cell adhesion molecule overexpression in breast cancer cell lines and clinical tumor tissue

Breast Cancer Research and Treatment

Volumn 129, Issue 2, 2011, Pages 347-360

  Hein, Sibyll ^a   Müller, Volkmar ^a   Köhler, Nadine ^a   Wikman, Harriet ^a   Krenkel, Sylke ^a   Streichert, Thomas ^a   Schweizer, Michaela ^a   Riethdorf, Sabine ^a   Assmann, Volker ^a   Ihnen, Maike ^a   Beck, Katrin ^a   Issa, Rana ^a   Jänicke, Fritz ^a   Pantel, Klaus ^a   Milde Langosch, Karin ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

ALCAM; Apoptosis; Breast cancer; Function; Immunohistochemistry; Invasion

Indexed keywords

ACTIVATED LEUKOCYTE CELL ADHESION MOLECULE; ANTINEOPLASTIC AGENT; CATHEPSIN D; COMPLEMENTARY DNA; CYTOKERATIN 7; ESTROGEN RECEPTOR; GELSOLIN; HORMONE; TRANSCRIPTION FACTOR ETS 2; VASCULOTROPIN;

ADULT; AGED; ARTICLE; BONE MARROW; BREAST CANCER; CANCER CELL CULTURE; CELL CLONE; CELL MOTILITY; CELL STRAIN MCF 7; CELL STRAIN MDA MB 231; COHORT ANALYSIS; CONTROLLED STUDY; DISSEMINATED TUMOR CELL; DNA MICROARRAY; ENZYME LINKED IMMUNOSORBENT ASSAY; FOLLOW UP; GENE EXPRESSION; GENE SILENCING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTRADUCTAL CARCINOMA; LONG TERM CARE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MASTECTOMY; OVERALL SURVIVAL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; RECURRENCE FREE INTERVAL; RETROSPECTIVE STUDY; TISSUE MICROARRAY; TREATMENT OUTCOME; TUMOR CELLS AND CELL LINES; WESTERN BLOTTING;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD; APOPTOSIS; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CELL ADHESION; CELL ADHESION MOLECULES, NEURONAL; CELL LINE, TUMOR; CELL MOVEMENT; CHI-SQUARE DISTRIBUTION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FETAL PROTEINS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASTIC CELLS, CIRCULATING; NEOVASCULARIZATION, PHYSIOLOGIC; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SURVIVAL RATE; TIME FACTORS; TISSUE ARRAY ANALYSIS; TRANSFECTION; UP-REGULATION;

EID: 80052643953     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-010-1219-y     Document Type: Article

References (48)

1. GW Swart 2002 Activated leukocyte cell adhesion molecule (CD166/ALCAM): developmental and mechanistic aspects of cell clustering and cell migration Eur J Cell Biol 81 313 321 12113472 10.1078/0171-9335-00256 1:CAS:528: DC%2BD38XmtlyrsLc%3D (Pubitemid 34692942)
2. N Uchida Z Yang J Combs O Pourquie M Nguyen R Ramanathan J Fu A Welply S Chen G Weddell, et al. 1997 The characterization, molecular cloning, and expression of a novel hematopoietic cell antigen from CD34+ human bone marrow cells Blood 89 2706 2716 9108388 1:CAS:528:DyaK2sXisFCisrs%3D (Pubitemid 27172555)
3. O Ohneda K Ohneda F Arai J Lee T Miyamoto Y Fukushima D Dowbenko LA Lasky T Suda 2001 ALCAM (CD166): its role in hematopoietic and endothelial development Blood 98 2134 2142 11568000 10.1182/blood.V98.7.2134 1:CAS:528:DC%2BD3MXnsVChtrw%3D
4. A Masedunskas JA King F Tan R Cochran T Stevens D Sviridov SF Ofori-Acquah 2006 Activated leukocyte cell adhesion molecule is a component of the endothelial junction involved in transendothelial monocyte migration FEBS Lett 580 2637 2645 16650408 10.1016/j.febslet.2006.04.013 1:CAS:528: DC%2BD28XksFaqsrw%3D
5. A Jezierska W Matysiak T Motyl 2006 ALCAM/CD166 protects breast cancer cells against apoptosis and autophagy Med Sci Monit 12 BR263 BR273 16865058 1:CAS:528:DC%2BD28Xps1Clurc%3D
6. K Ikeda T Quertermous 2004 Molecular isolation and characterization of a soluble isoform of activated leukocyte cell adhesion molecule that modulates endothelial cell function J Biol Chem 279 55315 55323 15496415 10.1074/jbc.M407776200 1:CAS:528:DC%2BD2cXhtFeis73E (Pubitemid 40066529)
7. JW van Kilsdonk RH Wilting M Bergers GN van Muijen J Schalkwijk LC van Kempen GW Swart 2008 Attenuation of melanoma invasion by a secreted variant of activated leukocyte cell adhesion molecule Cancer Res 68 3671 3679 18483249 10.1158/0008-5472.CAN-07-5767
8. WG Degen LC van Kempen EG Gijzen JJ van Groningen Y van Kooyk HP Bloemers GW Swart 1998 MEMD, a new cell adhesion molecule in metastasizing human melanoma cell lines, is identical to ALCAM (activated leukocyte cell adhesion molecule) Am J Pathol 152 805 813 9502422 1:CAS:528:DyaK1cXitFent7k%3D (Pubitemid 28110727)
9. LC van Kempen JJ van den Oord GN van Muijen UH Weidle HP Bloemers GW Swart 2000 Activated leukocyte cell adhesion molecule/CD166, a marker of tumor progression in primary malignant melanoma of the skin Am J Pathol 156 769 774 10702391 10.1016/S0002-9440(10)64943-7 (Pubitemid 30626933)
10. W Weichert T Knosel J Bellach M Dietel G Kristiansen 2004 ALCAM/CD166 is overexpressed in colorectal carcinoma and correlates with shortened patient survival J Clin Pathol 57 1160 1164 15509676 10.1136/jcp.2004.016238 1:CAS:528:DC%2BD2cXhtVKisb3K (Pubitemid 39486521)
11. M Sawhney A Matta MA Macha J Kaur S DattaGupta NK Shukla R Ralhan 2009 Cytoplasmic accumulation of activated leukocyte cell adhesion molecule is a predictor of disease progression and reduced survival in oral cancer patients Int J Cancer 124 2098 2105 19142865 10.1002/ijc.24192 1:CAS:528: DC%2BD1MXktVWnuro%3D
12. C Kahlert H Weber C Mogler F Bergmann P Schirmacher HG Kenngott U Matterne N Mollberg NN Rahbari U Hinz, et al. 2009 Increased expression of ALCAM/CD166 in pancreatic cancer is an independent prognostic marker for poor survival and early tumour relapse Br J Cancer 101 457 464 19603023 10.1038/sj.bjc.6605136 1:CAS:528:DC%2BD1MXpsVKmsro%3D
13. A Verma NK Shukla SV Deo SD Gupta R Ralhan 2005 MEMD/ALCAM: a potential marker for tumor invasion and nodal metastasis in esophageal squamous cell carcinoma Oncology 68 462 470 16024937 10.1159/000086989 1:CAS:528: DC%2BD2MXnvFymsL0%3D (Pubitemid 41160978)
14. S Choi M Kobayashi J Wang H Habelhah F Okada J Hamada T Moriuchi Y Totsuka M Hosokawa 2000 Activated leukocyte cell adhesion molecule (ALCAM) and annexin II are involved in the metastatic progression of tumor cells after chemotherapy with Adriamycin Clin Exp Metastasis 18 45 50 11206837 10.1023/A:1026507713080 1:CAS:528:DC%2BD3MXhtVaqtb8%3D (Pubitemid 32096048)
15. G Kristiansen C Pilarsky C Wissmann C Stephan L Weissbach V Loy S Loening M Dietel A Rosenthal 2003 ALCAM/CD166 is up-regulated in low-grade prostate cancer and progressively lost in high-grade lesions Prostate 54 34 43 12481253 10.1002/pros.10161 (Pubitemid 36043834)
16. D Mezzanzanica M Fabbi M Bagnoli S Staurengo M Losa E Balladore P Alberti L Lusa A Ditto S Ferrini, et al. 2008 Subcellular localization of activated leukocyte cell adhesion molecule is a molecular predictor of survival in ovarian carcinoma patients Clin Cancer Res 14 1726 1733 18347173 10.1158/1078-0432.CCR- 07-0428 1:CAS:528:DC%2BD1cXjtlejtLc%3D (Pubitemid 351469457)
17. JA King SF Ofori-Acquah T Stevens AB Al-Mehdi O Fodstad WG Jiang 2004 Activated leukocyte cell adhesion molecule in breast cancer: prognostic indicator Breast Cancer Res 6 R478 R487 15318930 10.1186/bcr815 1:CAS:528:DC%2BD2cXmtVegt7g%3D
18. M Burkhardt E Mayordomo KJ Winzer F Fritzsche T Gansukh S Pahl W Weichert C Denkert H Guski M Dietel, et al. 2006 Cytoplasmic overexpression of ALCAM is prognostic of disease progression in breast cancer J Clin Pathol 59 403 409 16484444 10.1136/jcp.2005.028209 1:CAS:528:DC%2BD28XktVajsLs%3D
19. SR Davies C Dent G Watkins JA King K Mokbel WG Jiang 2008 Expression of the cell to cell adhesion molecule, ALCAM, in breast cancer patients and the potential link with skeletal metastasis Oncol Rep 19 555 561 18202807 (Pubitemid 351176120)
20. M Ihnen V Müller RM Wirtz C Schröder S Krenkel I Witzel BW Lisboa F Jänicke K Milde-Langosch 2008 Predictive impact of activated leukocyte cell adhesion molecule (ALCAM/CD166) in breast cancer Breast Cancer Res Treat 112 419 427 18172759 10.1007/s10549-007-9879-y 1:CAS:528: DC%2BD1cXhtl2mu7nP
21. Schröder C, Schumacher U, Müller V, Wirtz RM, Streichert T, Richter U, Wicklein D, Milde-Langosch K (2010) The transcription factor Fra-2 promotes mammary tumour progression by changing the adhesive properties of breast cancer cells. Eur J Cancer. doi: 10.1016/j.ejca.2010.1002.1008
22. K Milde-Langosch S Janke I Wagner C Schröder T Streichert AM Bamberger F Jänicke T Löning 2008 Role of Fra-2 in breast cancer: influence on tumor cell invasion and motility Breast Cancer Res Treat 107 337 347 17393299 10.1007/s10549-007-9559-y 1:CAS:528:DC%2BD1cXht1Sgtro%3D (Pubitemid 351172111)
23. K Pantel G Schlimok M Angstwurm D Weckermann W Schmaus H Gath B Passlick JR Izbicki G Riethmuller 1994 Methodological analysis of immunocytochemical screening for disseminated epithelial tumor cells in bone marrow J Hematother 3 165 173 7530132 10.1089/scd.1.1994.3.165 1:STN:280:DyaK2M7ivVKmsQ%3D%3D
24. A-M Bamberger C Methner BW Lisboa C Städtler HM Schulte T Löning K Milde-Langosch 1999 Expression pattern of the AP-1 family in breast cancer: association of fosB expression with a well-differentiated, receptor-positive phenotype Int J Cancer 84 553 558 10.1002/(SICI)1097- 0215(19991022)84:5<533::AID-IJC16>3.0.CO;2-J
25. LM McShane DG Altman W Sauerbrei SE Taube M Gion GM Clark 2006 REporting recommendations for tumor MARKer prognostic studies (REMARK) Breast Cancer Res Treat 100 229 235 16932852 10.1007/s10549-006-9242-8 (Pubitemid 44631925)
26. S Braun FD Vogl B Naume W Janni MP Osborne RC Coombes G Schlimok IJ Diel B Gerber G Gebauer, et al. 2005 A pooled analysis of bone marrow micrometastasis in breast cancer N Engl J Med 353 793 802 16120859 10.1056/NEJMoa050434 1:CAS:528:DC%2BD2MXovVKlu7s%3D (Pubitemid 41215488)
27. GW Swart PC Lunter JW Kilsdonk LC Kempen 2005 Activated leukocyte cell adhesion molecule (ALCAM/CD166): signaling at the divide of melanoma cell clustering and cell migration? Cancer Metastasis Rev 24 223 236 15986133 10.1007/s10555-005-1573-0 1:CAS:528:DC%2BD2MXls1agsLc%3D (Pubitemid 40922796)
28. E Liaudet-Coopman M Beaujouin D Derocq M Garcia M Glondu-Lassis V Laurent-Matha C Prebois H Rochefort F Vignon 2006 Cathepsin D: newly discovered functions of a long-standing aspartic protease in cancer and apoptosis Cancer Lett 237 167 179 16046058 10.1016/j.canlet.2005.06.007 1:CAS:528: DC%2BD28XltF2qsbc%3D (Pubitemid 43777078)
29. SS Ohri A Vashishta M Proctor M Fusek V Vetvicka 2008 The propeptide of cathepsin D increases proliferation, invasion and metastasis of breast cancer cells Int J Oncol 32 491 498 18202773 1:CAS:528:DC%2BD1cXitFWhtLk%3D (Pubitemid 351188316)
30. M Koslowski U Sahin R Mitnacht-Kraus G Seitz C Huber O Tureci 2007 A placenta-specific gene ectopically activated in many human cancers is essentially involved in malignant cell processes Cancer Res 67 9528 9534 17909063 10.1158/0008-5472.CAN-07-1350 1:CAS:528:DC%2BD2sXhtFSnurjM (Pubitemid 47535943)
31. NE Willmarth A Baillo ML Dziubinski K Wilson DJ Riese II SP Ethier 2009 Altered EGFR localization and degradation in human breast cancer cells with an amphiregulin/EGFR autocrine loop Cell Signal 21 212 219 18951974 10.1016/j.cellsig.2008.10.003 1:CAS:528:DC%2BD1cXhsFamtLfE
32. T Tot 2002 Cytokeratins 20 and 7 as biomarkers: usefulness in discriminating primary from metastatic adenocarcinoma Eur J Cancer 38 758 763 11937308 10.1016/S0959-8049(02)00008-4 1:CAS:528:DC%2BD38XisFWhsLg%3D (Pubitemid 34280319)
33. J Pratap A Javed LR Languino AJ van Wijnen JL Stein GS Stein JB Lian 2005 The Runx2 osteogenic transcription factor regulates matrix metalloproteinase 9 in bone metastatic cancer cells and controls cell invasion Mol Cell Biol 25 8581 8591 16166639 10.1128/MCB.25.19.8581-8591.2005 1:CAS:528:DC%2BD2MXhtVKqsLfN (Pubitemid 41369178)
34. P Shore 2005 A role for Runx2 in normal mammary gland and breast cancer bone metastasis J Cell Biochem 96 484 489 16052475 10.1002/jcb.20557 1:CAS:528:DC%2BD2MXhtFSrt7vN (Pubitemid 41504647)
35. J Akech JJ Wixted K Bedard M van der Deen S Hussain TA Guise AJ van Wijnen JL Stein LR Languino DC Altieri, et al. 2010 Runx2 association with progression of prostate cancer in patients: mechanisms mediating bone osteolysis and osteoblastic metastatic lesions Oncogene 29 811 821 19915614 10.1038/onc.2009.389 1:CAS:528:DC%2BD1MXhsVWlsLjP
36. S Singer M Malz E Herpel A Warth M Bissinger M Keith T Muley M Meister H Hoffmann R Penzel, et al. 2009 Coordinated expression of stathmin family members by far upstream sequence element-binding protein-1 increases motility in non-small cell lung cancer Cancer Res 69 2234 2243 19258502 10.1158/0008-5472. CAN-08-3338 1:CAS:528:DC%2BD1MXjtFyqt7g%3D
37. K Bartkowiak M Wieczorek F Buck S Harder J Moldenhauer KE Effenberger K Pantel J Peter-Katalinic BH Brandt 2009 Two-dimensional differential gel electrophoresis of a cell line derived from a breast cancer micrometastasis revealed a stem/progenitor cell protein profile J Proteome Res 8 2004 2014 19714817 10.1021/pr8009758 1:CAS:528:DC%2BD1MXhslyjt7s%3D
38. E Ioachim A Charchanti E Briasoulis V Karavasilis H Tsanou DL Arvanitis NJ Agnantis N Pavlidis 2002 Immunohistochemical expression of extracellular matrix components tenascin, fibronectin, collagen type IV and laminin in breast cancer: their prognostic value and role in tumour invasion and progression Eur J Cancer 38 2362 2370 12460779 10.1016/S0959-8049(02)00210-1 1:CAS:528: DC%2BD38XptFGls7k%3D (Pubitemid 35387487)
39. J Helleman MP Jansen K Ruigrok-Ritstier IL van Staveren MP Look ME Meijer-van Gelder AM Sieuwerts JG Klijn S Sleijfer JA Foekens, et al. 2008 Association of an extracellular matrix gene cluster with breast cancer prognosis and endocrine therapy response Clin Cancer Res 14 5555 5564 18765548 10.1158/1078-0432.CCR-08-0555 1:CAS:528:DC%2BD1cXhtVKmsbbK
40. Y Buggy TM Maguire E McDermott AD Hill N O'Higgins MJ Duffy 2006 Ets2 transcription factor in normal and neoplastic human breast tissue Eur J Cancer 42 485 491 16380248 10.1016/j.ejca.2005.10.018 1:CAS:528:DC%2BD28XhsFOjsLc%3D (Pubitemid 43227927)
41. C Swanton J Downward 2008 Unraveling the complexity of endocrine resistance in breast cancer by functional genomics Cancer Cell 13 83 85 18242507 10.1016/j.ccr.2008.01.021 1:CAS:528:DC%2BD1cXitFWrs78%3D (Pubitemid 351163166)
42. S Chen S McLean DE Carter A Leask 2007 The gene expression profile induced by Wnt 3a in NIH 3T3 fibroblasts J Cell Commun Signal 1 175 183 18600477 10.1007/s12079-007-0015-x
43. N Gavert M Conacci-Sorrell D Gast A Schneider P Altevogt T Brabletz A Ben-Ze'ev 2005 L1, a novel target of beta-catenin signaling, transforms cells and is expressed at the invasive front of colon cancers J Cell Biol 168 633 642 15716380 10.1083/jcb.200408051 1:CAS:528:DC%2BD2MXhsVCjsr8%3D (Pubitemid 40271028)
44. F Meier S Busch D Gast A Goppert P Altevogt E Maczey S Riedle C Garbe B Schittek 2006 The adhesion molecule L1 (CD171) promotes melanoma progression Int J Cancer 119 549 555 16506207 10.1002/ijc.21880 1:CAS:528:DC%2BD28XmtlyjsrY%3D (Pubitemid 43955707)
45. C Schröder U Schumacher M Fogel F Feuerhake V Müller RM Wirtz P Altevogt S Krenkel F Jänicke K Milde-Langosch 2009 Expression and prognostic value of L1-CAM in breast cancer Oncol Rep 22 1109 1117 19787228
46. A Jezierska WP Olszewski J Pietruszkiewicz W Olszewski W Matysiak T Motyl 2006 Activated leukocyte cell adhesion molecule (ALCAM) is associated with suppression of breast cancer cells invasion Med Sci Monit 12 BR245 BR256 16810131 1:CAS:528:DC%2BD28XotlSrtLk%3D
47. K Pantel C Alix-Panabieres S Riethdorf 2009 Cancer micrometastases Nat Rev Clin Oncol 6 339 351 19399023 10.1038/nrclinonc.2009.44 1:CAS:528: DC%2BD1MXms12gtbw%3D
48. MT Wiiger HB Gehrken O Fodstad GM Maelandsmo Y Andersson 2010 A novel human recombinant single-chain antibody targeting CD166/ALCAM inhibits cancer cell invasion in vitro and in vivo tumour growth Cancer Immunol Immunother 59 1665 1674 20635083 10.1007/s00262-010-0892-3 1:CAS:528:DC%2BC3cXhtVyrtrvP